Search

Author/Creator Tarhini, Ahmad A.

1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016)

Authors:
Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia Masvidal; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine A.; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy A.;...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4(2016)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG‐ACRIN Cancer Research Group (E2607). Issue 14 (23rd March 2017)

Authors:
Kalinsky, Kevin; Lee, Sandra; Rubin, Krista M.; Lawrence, Donald P.; Iafrarte, Anthony J.; Borger, Darell R.; Margolin, Kim A.; Leitao, Mario M.; Tarhini, Ahmad A.; Koon, Henry B.; Pecora, Andrew L.; Jaslowski, Anthony J.; Cohen, Gary I.; Kuzel, Timothy M.; Lao, Christopher D.; Kirkwood, John M.
Journal:
Cancer
Issue:
Volume 123:Issue 14(2017)
Page Start:
2688
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A unique gene expression signature is significantly differentially expressed in tumor-positive or tumor-negative sentinel lymph nodes in patients with melanoma. Issue 5 (October 2017)

Authors:
Tarhini, Ahmad A.; Floros, Theofanis; Lin, Hui-Min; Lin, Yan; Rahman, Zahra; Ashraf, Madeeha; Vallabhaneni, Priyanka; Sander, Cindy; Rao, Uma N.M.; Panelli, Monica; LaFramboise, William F.; Kirkwood, John M.
Journal:
Melanoma research
Issue:
Volume 27:Issue 5(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0. Issue 1 (30th May 2018)

Authors:
Sullivan, Ryan J.; Atkins, Michael B.; Kirkwood, John M.; Agarwala, Sanjiv S.; Clark, Joseph I.; Ernstoff, Marc S.; Fecher, Leslie; Gajewski, Thomas F.; Gastman, Brian; Lawson, David H.; Lutzky, Jose; McDermott, David F.; Margolin, Kim A.; Mehnert, Janice M.; Pavlick, Anna C.; Richards, Jon M.; R...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 6:Issue 1(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma. Issue 1 (15th September 2015)

Authors:
Tarhini, Ahmad A.; Zahoor, Haris; Lin, Yan; Malhotra, Usha; Sander, Cindy; Butterfield, Lisa H.; Kirkwood, John M.
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 1(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134. Issue 2 (27th September 2022)

Authors:
Atkins, Michael B.; Lee, Sandra J.; Chmielowski, Bartosz; Tarhini, Ahmad A.; Cohen, Gary I.; Truong, Thach-Giao; Moon, Helen H.; Davar, Diwakar; O'Rourke, Mark; Stephenson, Joseph J.; Curti, Brendan D.; Urba, Walter J.; Brell, Joanna M.; Funchain, Pauline; Kendra, Kari L.; Ikeguchi, Alexandra P.;...
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 2(2023)
Page Start:
186
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗